4 Results for "

ataxia potential

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ataxia potential" in MCE Product Catalog:

Cat. No.: HY-102070
CAS No.: 1063331-94-1
Purity:  99.62%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC50s are 1.8 and 0.14 μM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias .
loading...
    loading...
Cat. No.: HY-123359
CAS No.: 414909-09-4
Research Areas:  

Others

RTC14 is a read-through compound (RTC) that can induce ribosomes to bypass nonsense mutations in mRNA and allow the production of full-length functional proteins. RTC14 has the potential to be used in the research of various genetic disorders, such as nonsense mutations in the ataxia-telangiectasia mutated (ATM) gene and the dystrophin gene .
loading...
    loading...
Cat. No.: HY-144435
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-11 (Compound Hit01) is a potent inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase. ATR kinase is a key regulating protein within the DNA damage response (DDR), responsible for sensing replication stress (RS). ATR-IN-11 is a promising lead compound for subsequent agent discovery targeting ATR kinase. ATR-IN-11 has the potential for the research of cancer disease .
loading...
    loading...
Cat. No.: HY-133929
CAS No.: 36889-15-3
Synonyms: SCH-14342
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Gentamicin B (SCH-14342) is an aminoglycoside antibiotic that can be isolated from Micromonospora echinospora. Gentamicin B can be used for the research of ataxia potential and renal toxicity .
loading...
    loading...